193 These studies prove that PRMTs are potential targets for cancer therapy, and several PRMTs inhibitors are currently in clinical trials (Table 1)
Benton CB, Al Rawi A, Wang F, Zhang J, Jorgensen JL, Mu H, Schober W, Alaniz Z, Gumbs C, Futreal A, Garcia-Manero G, Kantarjian HM, Navin N, Konopleva MY, Andreeff M
This approach ensures precise drug delivery to the disease site, thereby maximizing efficacy and mitigating the risk of off-target systemic effects, a crucial consideration for long-term COPD management
CD63 contributes to stability, biogenesis, cargo sorting, and interaction with target cells, influencing cell-to-cell communication [48]
Key Takeaway: Success with high-dose antioxidants relies on three pillars: sterile and accurate preparation, professional guidance to avoid interactions, and a "foundations-first" approach to daily health